ACB logo

AURORA CANNABIS INC

ACBNASDAQ
🏆 #3540 by market capUS Equity
$4.04▼ $0.05 (−1.22%)
Market closed · at close
🔔
Track ACB
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.2%
7d▼ 4.5%
14d▲ 5.4%
30d▼ 0.4%
ytd▼ 4.2%
1y▼ 32.4%
🏦Market Cap
$250M
Small Cap
📈Revenue Growth (YoY)
-6.6%
Declining
📊Gross Margin
32.1%
Moderate
💵FCF Margin
-17.6%
Thin
⚖️P/S Ratio
1.2x
Cheap
Otter Score
40
Weak

Trading Snapshot

Day Range
$4.02 – $4.07
52-Week Range
$2.56 – $6.67
Volume
$3.71B
Avg Volume
$4.10B
Shares Outstanding
61.9M
Next Earnings
Oct 25, 2026

Fundamentals Snapshot

Annual Revenue
$321M
Last Q Revenue
$68M
P/E Ratio
-3.0
P/S Ratio
1.2x
EPS (TTM)
$-1.80
Dividend Yield
0.00%
Dilution (1yr)
+7.6%

Why Investors Own ACB

  • ✓High-growth profile — revenue up +1.3% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 34% gross margin and 23% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ACB logo

AURORA CANNABIS INC

ACB
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$321M▼ −6.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
42.6%▼ −22.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$47M▼ −1043.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$36M▲ +1163.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
61.7M▲ +7.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$96M▲ +$140M YoY
StockOtter · stockotter.space

About AURORA CANNABIS INC

Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
40/100

Analyst Price Target

ⓘ
Average Target
$4.54
▲ +12.4% Upside
High Target$4.95
Low Target$3.49
Based on 12 analysts

Latest News & Updates

🚀
Reuters·2h ago

AURORA CANNABIS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
CNBC·5h ago

Analysts lift ACB price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Barron’s·1d ago

AURORA CANNABIS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.